drugset / Trial / NCT04062526

Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT

NCT04062526 ↗

Phase 0 Active not recruiting 11 enrolled University of Pennsylvania
Non-randomizedParallel-groupOpen-labelOther

Summary

The research study is being conducted to test how a specialized type of Positron Emission Tomography (PET/CT) scan could potentially be useful in diagnosing or monitoring treatment in people with Parkinson's disease. If the subject decide to be in this study he/she will have a PET/CT scans using an imaging drug called 18F-NOS which will be used to measure inflammation in the brain.

Timeline

Start
2019-08-14
Primary completion
2027-04
Completion
2027-04

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]NOS Diagnostic / imaging agent — —

Indications